Tripoint Drug Patent Portfolio
Tripoint owns 1 orange book drug protected by 5 US patents Given below is the list of Tripoint's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8431156 | Pharmaceutical composition | 31 Oct, 2027 | Active |
| US8470367 | Oral drug delivery system | 31 Oct, 2027 | Active |
| US8163306 | Oral drug delivery system | 03 Sep, 2027 | Active |
| US8425938 | Pharmaceutical composition | 22 Feb, 2026 | Active |
| US8535717 | Pharmaceutical composition | 22 Feb, 2026 | Active |
Latest Legal Activities on Tripoint's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Tripoint.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 24 Oct, 2023 | US8163306 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 17 Mar, 2021 | US8535717 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 28 Dec, 2020 | US8470367 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 30 Oct, 2020 | US8431156 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 23 Oct, 2020 | US8425938 |
| Post Issue Communication - Certificate of Correction | 25 Feb, 2020 | US8470367 |
|
Email Notification
Critical
| 19 Oct, 2019 | US8470367 |
| Filing Receipt - Corrected | 18 Oct, 2019 | US8470367 |
| Mail-Petition Decision - Granted | 18 Oct, 2019 | US8470367 |
|
Email Notification
Critical
| 18 Oct, 2019 | US8470367 |
|
Petition Decision - Granted
Critical
| 17 Oct, 2019 | US8470367 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 22 Jul, 2019 | US8163306 |
| Petition Entered | 09 May, 2019 | US8470367 |
| Post Issue Communication - Certificate of Correction | 30 Apr, 2014 | US8470367 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 17 Sep, 2013 | US8535717 |
Tripoint's Family Patents
Tripoint drugs have patent protection in a total of 19 countries. It's US patent count contributes only to 25.0% of its total global patent coverage. 7 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Tripoint Drug List
Given below is the complete list of Tripoint's drugs and the patents protecting them.
1. Elepsia Xr
Elepsia Xr is protected by 5 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8431156 | Pharmaceutical composition |
31 Oct, 2027
(3 years from now)
| Active |
| US8470367 | Oral drug delivery system |
31 Oct, 2027
(3 years from now)
| Active |
| US8163306 | Oral drug delivery system |
03 Sep, 2027
(2 years from now)
| Active |
| US8425938 | Pharmaceutical composition |
22 Feb, 2026
(1 year, 4 months from now)
| Active |
| US8535717 | Pharmaceutical composition |
22 Feb, 2026
(1 year, 4 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Elepsia Xr's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List